Post

New research · Ophthalmology
BMJ open ophthalmology · 16h
Cohort studyBMJ open ophthalmology · 2025

Role of additional topotecan injections (plus two) in reducing recurrence rate in retinoblastoma of group D and group E patients: a retrospective study.

Xintong Lin, Zhuqing Zheng, Haifeng Chen … Kang Xue
Read paper
OphthalmologyCohort study

Extra topotecan injections after seed regression saved 92.3% of retinoblastoma eyes.

Role of additional topotecan injections (plus two) in reducing recurrence rate in retinoblastoma of group D and group E patients: a retrospective study.

Xintong Lin … Kang Xue
BMJ open ophthalmology · 2025
Purpose

To evaluate the effectiveness of administering additional intravitreal topotecan injections (plus two) in reducing the recurrence rate in patients with advanced retinoblastoma (retinoblastoma).

Methods

This retrospective, non-comparative and interventional study encompassed 26 eyes of 25 patients with retinoblastoma, treated between January 2019 and April 2024.

n = 26 eyes
Results
92.3%
extra injections after seeds cleared saved the eye without removal
n = 26 eyes
More results

The median age of the patients was 26 months, with 57.7% belonging to group D and 42.3% to group E of retinoblastoma classification.

There were no recurrences of vitreous seeds.

No cases of systemic metastasis or death were reported.

“
Conclusion · 1 of 3

Administering additional intravitreal topotecan injections (plus two) following the complete regression of vitreous seeds may contribute to reducing the recurrence rate in patients with retinoblastoma.

Conclusion · 2 of 3

This approach enhances the long-term efficacy of intravitreal injections, thereby contributing to higher eye salvage rates. However, the retrospective, non-randomised design and small sample size remain limitations.

Conclusion · 3 of 3

Multicentre prospective studies are warranted to validate these findings and refine treatment protocols.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving